Open Access

Dual vs triple therapy in atrial fibrillation post-PCI: how has the story evolved?

Congress Presentation

About the speaker

Professor Christopher Paul Cannon

Brigham and Women's Hospital, Boston (United States of America)
38 presentations
0 follower

3 more presentations in this session

New evidence from RE-DUAL PCI: what do the data tell us?

Speaker: Professor S. Hohnloser (Frankfurt, DE)


Comprehensive patient care: from OAC choice to post-PCI (and beyond).

Speaker: Professor G. Nickenig (Bonn, DE)


Improving care decisions in patients with atrial fibrillation: panel discussion and Q&A.

Speaker: Professor C. Cannon (Boston, US)


Access the full session

Translating trials to clinical practice: is dual therapy the new standard of care for atrial fibrillation patients post-PCI?

Speakers: Professor C. Cannon, Professor S. Hohnloser, Professor G. Nickenig, Professor C. Cannon

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb